158 related articles for article (PubMed ID: 17456912)
1. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis.
Zodpey SP
Indian J Dermatol Venereol Leprol; 2007; 73(2):86-93. PubMed ID: 17456912
[TBL] [Abstract][Full Text] [Related]
2. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
Zodpey SP
Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.
Tawfik GM; Biala M; Yousef YM; Tiwari R; Dobs M; Lotfy CI; Farrag DA; Hue AT; Yotsu RR; Huy NT
Clin Microbiol Infect; 2021 Dec; 27(12):1754-1761. PubMed ID: 34332107
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India.
Rahete NP; Zodpey SP; Kamble KM
Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467
[TBL] [Abstract][Full Text] [Related]
7. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
[TBL] [Abstract][Full Text] [Related]
8. Differential protective effect of bacillus Calmette-Guerin vaccine against multibacillary and paucibacillary leprosy in Nagpur, India.
Kulkarni HR; Zodpey SP
Public Health; 1999 Nov; 113(6):311-3. PubMed ID: 10637526
[TBL] [Abstract][Full Text] [Related]
9. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control.
Merle CS; Cunha SS; Rodrigues LC
Expert Rev Vaccines; 2010 Feb; 9(2):209-22. PubMed ID: 20109030
[TBL] [Abstract][Full Text] [Related]
10. Bacillus of Calmette and Guérin (BCG) and the risk of leprosy in Ciudad del Este, Paraguay, 2016-2017.
Cuevas NC; Cardenas VM
Epidemiol Health; 2021; 43():e2021060. PubMed ID: 34525502
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of Bacillus Calmette Guerin (BCG) against leprosy: a population-based case-control study in Nagpur, India.
Zodpey SP; Bansod BS; Shrikhande SN; Maldhure BR; Kulkarni SW
Lepr Rev; 1999 Sep; 70(3):287-94. PubMed ID: 10603718
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India.
Zodpey SP; Shrikhande SN; Salodkar AD; Maldhure BR; Kulkarni SW
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):309-15. PubMed ID: 9934357
[TBL] [Abstract][Full Text] [Related]
13. The role of BCG in prevention of leprosy: a meta-analysis.
Setia MS; Steinmaus C; Ho CS; Rutherford GW
Lancet Infect Dis; 2006 Mar; 6(3):162-70. PubMed ID: 16500597
[TBL] [Abstract][Full Text] [Related]
14. BCG vaccine and leprosy household contacts: Protective effect and probability to becoming sick during follow-up.
Gomes RR; Antunes DE; Dos Santos DF; Sabino EFP; Oliveira DB; Goulart IMB
Vaccine; 2019 Oct; 37(43):6510-6517. PubMed ID: 31500969
[TBL] [Abstract][Full Text] [Related]
15. Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies.
El-Zein M; Parent ME; Benedetti A; Rousseau MC
Int J Epidemiol; 2010 Apr; 39(2):469-86. PubMed ID: 19822573
[TBL] [Abstract][Full Text] [Related]
16. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.
Pönnighaus JM; Fine PE; Sterne JA; Wilson RJ; Msosa E; Gruer PJ; Jenkins PA; Lucas SB; Liomba NG; Bliss L
Lancet; 1992 Mar; 339(8794):636-9. PubMed ID: 1347338
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
[TBL] [Abstract][Full Text] [Related]
19. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Bacillus Calmette Guerin (BCG) vaccination in prevention of pulmonary tuberculosis.
Zodpey SP; Maldhure BR; Kulkarni SW
J Commun Dis; 2004 Sep; 36(3):159-65. PubMed ID: 16509251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
